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Introduction
Perinatal infant mortality has decreased, but congenital
malformations remain a major cause of mortality in
infants of mothers with established diabetes [1–3].
Even in established cases of diabetes mellitus, 95% of
pregnant women are first seen after the period of
organogenesis (> 8 weeks). Offspring of women with
pregestational diabetes mellitus are at increased risk for
congenital malformations, largely attributable to poor
periconceptional glycemic control [4,5].
Caudal regression syndrome is an uncommon
malformation in the general population, but occurs in
about 1 in 350 infants of diabetic mothers, representing
an increase of about 200-fold over the rate reported
from the general population [6]. Outpatient
preconception care and periconceptional euglycemic
control are the best ways to reduce the risk of major
congenital anomalies among the offspring of women
with pregestational diabetes mellitus.
Case Report
A 33-year-old Chinese woman, gravida 5, para 3, abortus
1, received regular antenatal care without remarkable
abnormal findings. In spite of being diagnosed with
gestational diabetes requiring insulin treatment in her
previous third pregnancy, this diabetic mother received
no postpartum follow-up or preconception care in the
current pregnancy. A routine 50-g 1-hour glucose
challenge test performed at 29 weeks of gestation gave
a plasma glucose level of 376 mg/dL. Fasting plasma
glucose sampled at 30 weeks of gestation was also
elevated at 234 mg/dL, and pregestational diabetes was
diagnosed. Follow-up glycosylated hemoglobin (HbA1c)
was 10.7%.
SUMMARY
Objective: Caudal regression syndrome is a rare congenital anomaly. We report a case of caudal regression
syndrome and emphasize the importance of preconception care and periconceptional euglycemic control, which
should have been provided much earlier for this diabetic mother.
Case Report: This neonate with caudal regression syndrome was born to a 33-year-old Chinese woman with
pregestational diabetes. Postpartum magnetic resonance imaging of this female infant showed agenesis of the
lumbosacral spine from L5 and partial agenesis of L4. In spite of being diagnosed with gestational diabetes
in her previous third pregnancy, the diabetic mother had received no postpartum follow-up or preconception
care in the current pregnancy.
Conclusion: Preconception care and postpartum follow-up for women with diabetes is important. Outpatient
preconception care is needed to reduce the risk of major congenital anomalies among the offspring of women
with pregestational diabetes mellitus. [Taiwanese J Obstet Gynecol 2005;44(3):264–266]
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The mother was 150 cm tall and weighed 58 kg. Her
mother had diabetes. She was hospitalized, and insulin
therapy was immediately begun. She began monitoring
her glucose before each meal and at bedtime, making
daily adjustments in her insulin intake. She received
nutrition education explaining appropriate caloric intake
and emphasizing upper body exercise.
A live 2,115-g female baby, born by vaginal delivery
at 34 weeks because of premature rupture of membranes,
had Apgar scores of 8 and 9 at 1 and 5 minutes,
respectively. Club feet were found bilaterally. There was
complete agenesis of the vertebral column below the
fifth lumbar vertebra and partial agenesis of the vertebral
column below the fourth lumbar vertebra (Figure).
In her previous pregnancy with gestational diabetes
mellitus and insulin therapy, a 2,595-g grossly normal
female baby was delivered at 32 weeks of gestation.
That child has had no specific abnormal findings in her
lumbosacral spine or feet to the present age of 6 years.
The blood glucose levels of this diabetic mother
improved postpartum, and she was discharged with no
medications. At her 2-week postpartum visit, home
blood glucose monitoring indicated values ranging from
72 to 328 mg/dL, mostly in the 200–300 mg/dL range.
A repeat HbA1c was 8.7%. She restarted an oral
hypoglycemic drug.
This diabetic mother met the criteria for high risk
based on her age and a first-degree family member with
a history of type 2 diabetes. The child has normal
mental function and, with a series of orthopedic
interventions and physical rehabilitation, her quality of
life is expected to improve.
Discussion
Risk assessment has to be performed early in a diabetic
pregnancy. The glucose challenge test (measures plasma
glucose 1 hour after a 50-g oral glucose load) is an
appropriate screening test for an average-risk woman
with no symptoms of diabetes at 24–28 weeks’ gestation.
For high-risk women, a casual plasma glucose test will
eliminate the need for a glucose challenge. For women
who fail the initial screening, physicians can proceed
with the oral glucose tolerance test (OGTT). Screening
criteria for diagnosing diabetes include either symptoms
of diabetes plus a casual plasma glucose of more than
200 mg/dL (11.1 mmol/L), fasting plasma glucose of
more than 126 mg/dL (7.0 mmol/L), or a 2-hour plasma
glucose of more than 200 mg/dL (11.1 mmol/L) during
an OGTT [7,8].
In the case reported here, the diabetic mother most
likely would have met the first criterion if a casual blood
glucose test had been performed. Her 1-hour plasma
glucose following glucose challenge was 376 mg/dL,
which suggests that her casual glucose would also have
been quite high.
Medical nutrition therapy (MNT) is an important
component of diabetes management. However, with
this degree of hyperglycemia, MNT would have been
inadequate by itself. Treatment for gestational diabetes
includes insulin if fasting blood glucose levels are greater
than 95 mg/dL (5.3 mmol/L) or 2-hour postprandial
values are more than 120 mg/dL (6.7 mmol/L) [8].
While HbA1c values cannot be used for diagnostic
purposes, they further confirmed the significant degree
of hyperglycemia in this case. Plasma glucose values
initially improved in the immediate postpartum period
and she was sent home without medications but was
instructed to continue home glucose monitoring.
Many of the embryonic and fetal abnormalities that
occur in pregnancy complicated by maternal diabetes
are the result of development in a metabolically abnormal
environment. Diabetic embryopathy (birth defects and
spontaneous abortions) results from maternal metabolic
abnormalities during the first 6–7 weeks of gestation.
Diabetic fetopathy (predominantly macrosomia and
neonatal hypoglycemia) results from fetal overnutrition
and hyperinsulinemia during the second and third
trimesters. Careful regulation of maternal metabolism
from the preconception period onwards can greatly
reduce or even eliminate the excess risks among infants
of diabetic mothers [9].
Caudal regression syndrome is more common in
infants of diabetic mothers than in the general
population [9]. Surviving infants usually have normal
mental function but they require extensive urologic and
Figure. Postnatal magnetic resonance imaging (sagittal view)
on the 19th day of age: (A) T2-weighted image showing agenesis
of the vertebral column below the level of L5 and partial
agenesis of L4; (B) T1-weighted image showing a typical blunt-
ended conus at level T11.
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orthopedic assistance. Their long-term morbidity
consists mostly of neurogenic bladder dysfunction
resulting in progressive renal damage and disabling
neuromuscular deficits of the lower extremities.
Neurosurgical and orthopedic interventions with
physical rehabilitation are indicated to improve the
quality of their lives [9].
A diabetic mother should receive multidisciplinary
care, including care from a diabetologist, obstetrician,
registered dietitian, and triage nurses. The mother had
visited all of these care providers as instructed. How-
ever, the communication among the various health care
providers seemed poor. The obstetrician performed a
glucose challenge test, followed the pregnancy through
prenatal care and took the blame. It seems that if all of
these providers had had the full information about this
case, the diagnosis would have been made earlier and
insulin therapy would have been initiated much sooner
than it was. Outpatient preconception care probably
reduces the risk of major congenital anomalies among
the offspring of women with pregestational diabetes
mellitus.
Many women with diabetes neither plan their
pregnancies nor achieve adequate glycemic control
before conception; strategies are thus needed to im-
prove access to preconception care and periconceptional
euglycemic control programs, and to maximize inter-
ventions, such as smoking cessation and exercise, to
improve pregnancy outcomes [4,10].
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